RE:Check out Resverlogix, T.RVX. Huge news: Further Analysis of the ASSURE Data Finds a Responder Group for RVX-208 with Statistically Significant Regression of Coronary Atherosclerosis. It undoes the news on June 27 which saw the stock tank from $3 to 23 cents. It should go back to $3 again and is trading at 95 cents.What does this have to do with FMS? Aren't you on the wrong site?